150 results
Page 6 of 8
8-K
EX-99.1
agh190w s0s
12 Jul 07
GTx’s Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
12:00am
8-K
EX-99.1
ztr6 gwv2g1x40
22 Feb 07
GTxREPORTS FOURTH QUARTER AND YEAR END 2006 RESULTS
12:00am
424B5
kypzx
14 Dec 06
Prospectus supplement for primary offering
12:00am
424B5
dstf30xki3u96
14 Dec 06
Prospectus supplement for primary offering
12:00am
8-K
rqfmtvzf0lzdsimu
14 Dec 06
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
th3aa
14 Dec 06
Entry into a Material Definitive Agreement
12:00am
8-K
uhs5 ccg8t
13 Dec 06
GTx Announces Registered Direct Common Stock Offering of $60.8 Million
12:00am
8-K
EX-99.1
o0zlaf6qa301zzudd
7 Sep 06
GTx’s PHASE III CLINICAL DEVELOPMENT OF ACAPODENE ON COURSE FOLLOWING PLANNED SAFETY REVIEW
12:00am
8-K
EX-99.1
g5jtcl9bkr6jnp0t7yy
7 Sep 06
Regulation FD Disclosure
12:00am
S-8
EX-23.1
93avn
11 Aug 06
Registration of securities for employees
12:00am
8-K
EX-99.1
mld xdxcm
27 Jul 06
GTX, Inc. Reports Second Quarter 2006 Financial Results
12:00am
8-K
EX-99.1
ov88i cekt
22 Jun 06
Other Events
12:00am